Efficacy and Safety of CRC01 in Participants With Severe, Refractory Systemic Lupus Erythematosus

NCT07364396 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
39
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Curocell Inc.